Certified as an NVIDIA Inception Program Partner
Epistra Inc. was certified as a partner of the “NVIDIA Inception Program,” an AI startup support program provided by NVIDIA Corporation, a leading provider of GPU deep learning platforms, on February 8, 2022.
Going forward, we plan to strengthen the development of our automated experimental design AI “Epistra Accelerate” with support from NVIDIA Corporation.
About the NVIDIA Inception Program
The NVIDIA Inception Program is designed to nurture startups driving industry transformation through advances in artificial intelligence and data science. Designed as a virtual incubator program, it supports members at critical stages such as product development, prototyping, and deployment, offering customized support packages including hardware grants, marketing support, and training from deep learning experts.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.